Cleveland Medical Devices spin-off company NeuroWave Systems Inc. is poised to introduce its first commercial product — the NeuroSense Monitor — without taking a single investor dollar. NeuroSense is ...
CHICAGO--(BUSINESS WIRE)--Neurowave Medical Technologies™ (NMT) will launch the OTC version of its popular ReliefBand® Voyager, an innovative and highly efficacious Transdermal Neuromodulation Medical ...
Medical device startup NeuroWave Systems Inc. has received the CE marking for its NeuroSense anesthesia monitor, enabling the company to sell its first product in Europe. The Cleveland Heights, Ohio ...
CHICAGO--(BUSINESS WIRE)--Neurowave Medical Technologies™ (NMT) introduced Nometex™, a new transdermal neuromodulation device to treat patients with chemotherapy-induced nausea and vomiting (CINV), at ...
We’ve already explored in detail why VR makes some of us sick and motion sickness definitely has a big part to play in that. One company that’s hoping it can provide a solution to the problem is ...
CHICAGO--(BUSINESS WIRE)-- Health care professionals, patients and payors are increasingly seeking safe first-line therapeutic alternatives that provide demonstrated efficacy without drug-related side ...
A neurotechnology company Reliefband debuted Reliefband Neurowave, the second generation of its wearable designed to combat the effects of VR-induced motion sickness. The Reliefband Neurowave will be ...
Reliefband Technologies, an American startup company showcased a unique wearable at the CES 2017. By the looks of it, the Reliefband Neurowave looks like just another fitness tracker. But then, it ...
ANN ARBOR, Mich. and TUSTIN, Calif., Nov. 2, 2015 /PRNewswire/ -- Biotronic NeuroNetwork announces the acquisition of Neurowave Monitoring in Tustin, CA. The combination of Biotronic and Neurowave ...
CHICAGO--(BUSINESS WIRE)-- Neurowave Medical Technologies™ (NMT) introduced Nometex™, a new transdermal neuromodulation device to treat patients with chemotherapy-induced nausea and vomiting (CINV), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results